Strattera is a brand-name oral capsule prescribed for attention deficit hyperactivity disorder (ADHD). Strattera contains the active drug atomoxetine. Strattera is FDA approved to treat ADHD in adults ...

Strattera vs. Ritalin: What Is the Difference? Strattera and Ritalin are medicines that children and adults can take to manage symptoms of attention deficit hyperactivity disorder (ADHD). Both drugs ...

Strattera (atomoxetine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Strattera comes as an oral capsule. Strattera is used in adults and certain ...

Based in Tampa, Florida, Virginia Pelley is a former women's magazine editor who has written health and fitness content for Men's Journal, Cosmopolitan magazine, the Chicago Tribune, ...

Strattera is a non-stimulant medication for ADHD that works by increasing norepinephrine in your brain. Common side effects of Strattera include dry mouth, nausea, and reduced appetite. Stimulants ...

Overview: Atomoxetine is used to help with attention deficit and hyperactivity disorder (ADHD) by improving focus and reducing impulsivity and hyperactivity. It works by increasing a natural substance ...

US drugmaker Eli Lilly says it will update the label of its attention-deficit hyperactivity disorder drug, Strattera (atomoxetine), to carry a "black box" warning, the strongest required by US ...

For as long as she can remember, 29-year-old Vanessa Jaramillo has struggled to concentrate — a problem that affected her school years and later caused challenges at work. The dog groomer from Georgia ...

Tips, tools, and support for living and thriving with ADHD ...

The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit ...

Eli Lilly could be facing generic competition far sooner than expected for Strattera, after a US court ruled that a key patent on the attention deficit hyperactivity disorder treatment is invalid. Eli ...

THE POWER of marketing can clearly be seen in the case of Strattera, Eli Lilly's new drug for attention deficit/hyperactivity disorder. The company is hoping its drug will help fill the gap left in ...